Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
New England Journal of MedicinePublished 29 November 2001Open access
Bryan Brown, Xue-Qiao Zhao, Alan Chait, Lloyd D. Fisher, Marian C. Cheung, Josh S. Morse
Citations1,982
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Simvastatin plus niacin provides marked clinical and angiographically measurable benefits in patients with coronary disease and low HDL levels, and the use of antioxidant vitamins in this setting must be questioned.
Abstract
Simvastatin plus niacin provides marked clinical and angiographically measurable benefits in patients with coronary disease and low HDL levels. The use of antioxidant vitamins in this setting must be questioned.
Keywords
MedicineNursing
Clinical ChemistryEstimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
32,475 Citations1972William T. Friedewald, Robert I. Levy +1 more
A method for estimating the cholesterol content of the serum low-density lipoprotein fraction (Sf0-20) is presented and comparison of this suggested procedure with the more direct procedure, in which the ultracentrifuge is used, yielded correlation coefficients of .94 to .99.
CirculationPrediction of Coronary Heart Disease Using Risk Factor Categories
9,621 Citations1998Peter W.F. Wilson, Ralph B. D’Agostino +4 more
A simple coronary disease prediction algorithm was developed using categorical variables, which allows physicians to predict multivariate CHD risk in patients without overt CHD.
New England Journal of MedicineBeyond Cholesterol
6,420 Citations1989Franklin H. Epstein, Daniel Steinberg +4 more
New England Journal of MedicinePrevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
5,299 Citations1998The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespecified cardiovascular events in patients with a history of myocardial infarction or unstable angina who had a broad range of initial cholesterol levels.
New England Journal of MedicineThe Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers
4,695 Citations1994The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group
No reduction in the incidence of lung cancer among male smokers is found after five to eight years of dietary supplementation with alpha-tocopherol or beta carotene, and this trial raises the possibility that these supplements may actually have harmful as well as beneficial effects.
The LancetDietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
3,803 Citations1999
Dietary supplementation with n-3 PUFA led to a clinically important and statistically significant benefit and vitamin E had no benefit and its effects on fatal cardiovascular events require further exploration.
CirculationHigh-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
3,187 Citations1989David J. Gordon, Jeffrey L. Probstfield +7 more
A consistent inverse relation of high-density lipoprotein cholesterol levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.
New England Journal of MedicineLack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
2,409 Citations1996Charles H. Hennekens, Julie E. Buring +10 more
In this trial among healthy men, 12 years of supplementation with beta carotene produced neither benefit nor harm in terms of the incidence of malignant neoplasms, cardiovascular disease, or death from all causes.
New England Journal of MedicineRegression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
2,166 Citations1990Greg Brown, John J. Albers +8 more
In men with coronary artery disease who were at high risk for cardiovascular events, intensive lipid-lowering therapy reduced the frequency of progression of coronary lesions, increased the frequencyof regression, and reduced the incidence of cardiovascular events.
PubMedDietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
2,065 Citations1999Roberto Marchioli, MG Franzosi +1 more
Dietary supplementation with n-3 PUFA led to a clinically important and satistically significant benefit and its effects on fatal cardiovascular events require further exploration.
New England Journal of MedicineVitamin E Supplementation and Cardiovascular Events in High-Risk Patients
1,956 Citations2000The Heart Outcomes Prevention Evaluation Study Investigators
In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years had no apparent effect on cardiovascular outcomes and there were no significant differences in the incidence of secondary cardiovascular outcomes or in death from any cause.
Free Radical Research CommunicationsContinuous Monitoring of<i>in Vztro</i>Oxidation of Human Low Density Lipoprotein
1,790 Citations1989H. Esterbauer, G Striegl +2 more
The kinetics of the oxidation of human low density lipoprotein (LDL) can be measured continuously by monitoring the change of the 234 nm diene absorption and the determination of the lag-phase is a convenient and objective procedure for determining the susceptibility of LDL from different donors towards oxidation as well as effects of pro- and antioxidants.
Journal of the American Statistical AssociationBiostatistics: A Methodology for the Health Sciences.
962 Citations1995Ralph B. D’Agostino, Lloyd D. Fisher +1 more
JAMARelation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events
922 Citations2001Sander J. Robins, Dorothea Collins +10 more
Concentrations of HDL-C achieved with gemfibrozil treatment predicted a significant reduction in CHD events in patients with low LDL-C levels, however, the change in HDL- C levels only partially explained the beneficial effect of gem fibroZil.
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid MetabolismHigh-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
831 Citations1990Sampath Parthasarathy, Joellen Barnett +1 more
It is suggested that HDL may play a protective role in atherogenesis by preventing the generation of an oxidatively modified LDL.
CirculationLipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
822 Citations1993B. Greg Brown, Xiaohui Zhao +2 more
The composite of data presented here supports the hypothesis that lipid-lowering therapy selectively depletes that relatively small but dangerous subgroup of fatty lesions containing a large lipid core and dense clusters of intimal macrophages, which are effectively stabilized and clinical event rate is accordingly decreased.
CirculationPlasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
353 Citations1993Nancy Phillips, David D. Waters +1 more
In patients with established coronary heart disease, increased levels of remnants of triglyceride-rich lipoproteins and decreased levels of high-density lipoprotein cholesterol appear to promote progression of coronary artery atherosclerosis, which in turn may lead to an untoward clinical event.
PubMedThe Münster Heart Study (PROCAM). Results of follow-up at 8 years.
336 Citations1998Gerd Assmann, Paul Cullen +1 more
A risk algorithm has been developed for men aged 40 to 65 years which takes into account the independent risk factors of HDL cholesterol, LDL cholesterol, triglycerides, fibrinogen, age, systolic blood pressure, cigarette smoking, presence of diabetes mellitus and family history of myocardial infarction and angina pectoris.
CirculationEvidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression
261 Citations1999Alberto Zambon, John E. Hokanson +2 more
These studies support the hypothesis that therapy-associated changes in HL alter LDL density, which favorably influences CAD progression, which is a new and potentially clinically relevant mechanism linking lipid-altering therapy to CAD improvement.
European Heart JournalMRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
258 Citations1999
The Heart Protection Study is large, it has included a wide range of patients at high risk of vascular events, and the treatment regimens being studied are well-tolerated and produce substantial effects on blood lipid and vitamin levels.
Journal of Lipid ResearchAltered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease
201 Citations1991MC Cheung, B. Greg Brown +2 more
The spectrum of HDL particle sizes in patients with CAD tends to be shifted toward the smaller particle when compared with the two control groups, and was observed in both NL and HL patients with HDL cholesterol (CH) values in the normal range.
Arteriosclerosis Thrombosis and Vascular BiologyAntioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
191 Citations2001Marian C. Cheung, Xue-Qiao Zhao +3 more
In CAD patients with low HDL-C, S-N substantially increased HDL2- C, Lp(A-I), and HDL particle size, and these favorable responses were blunted by the antioxidants used owing to a striking selective effect on Lp-I.
Current Opinion in LipidologyHepatic lipase
148 Citations1999Jonathan C. Cohen, Gloria Lena Vega +1 more
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid MetabolismQuantitative determination of human apolipoprotein Cc-III by electroimmunoassay
141 Citations1980Michael D. Curry, Walter J. McConathy +2 more
The levels of apolipoprotein C-III in patients with type V were significantly higher than in normal or other hyperlipoproteinemic phenotypes, and this sensitive, specific, rapid, precise and accurate electroimmunoassay is applicable to measurement of C- III polypeptide in whole serum and density classes.
Arteriosclerosis and Thrombosis A Journal of Vascular BiologyFamilial hypoalphalipoproteinemia in premature coronary artery disease.
119 Citations1993Jacques Genest, Jean‐Marie Bard +3 more
The data suggest that common forms of FHA in subjects with coronary artery disease represent a spectrum of overlapping disorders characterized by an increase in apoB-containing lipoproteins, especially LpB:E particles, and smaller, denser LDL particles.
American Journal of Clinical NutritionAntioxidant vitamin supplementation and lipid peroxidation in smokers
107 Citations1998Francene M. Steinberg, Alan Chait
It is indicated that an antioxidant-supplemented drink can reduce lipid peroxidation and susceptibility of LDL to oxidation in smokers and may ameliorate the oxidative stress of cigarette smoke.
The American Journal of MedicineTwelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the framingham offspring study
93 Citations1991P.W.F. Wilson, Keaven M. Anderson +2 more
This study confirms the importance of the common CHD risk factors of cigarette smoking and LDL-C, and extends the prognostic role of HDL-C in a middle-aged cohort, and reduces the impact of blood pressure, with or without use of hypertensive medications.
Arteriosclerosis Thrombosis and Vascular BiologyLowering of HDL <sub>2b</sub> by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia
81 Citations1995Jan Johansson, Anders Olsson +7 more
The correlation between drug-induced change in the relative HDL2b concentration and change in atherosclerosis was independent of the alteration in triglyceride concentration and could not be explained by treatment interaction.
Arteriosclerosis and Thrombosis A Journal of Vascular BiologyCholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease.
78 Citations1991M Dobiášová, J Stříbrná +3 more
FERHDL appears to be a sensitive and reliable functional measure of the particle size distribution in the HDL pool and one of potential clinical value in the assessment of risk for CAD.
Arteriosclerosis An Official Journal of the American Heart Association IncQuantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta.
74 Citations1985John R. Guyton, Thomas Bocan +1 more
The results support the concept that an Interaction between elastln or Its associated components and llplds or llpoprotelns may be Important In extracellular llpid deposition In human arteries.
Journal of Lipid ResearchLow levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype
70 Citations2000Robert W. Mahley, Judy Pépin +4 more
The gender-specific impact of the apoE genotype on HDL-C and LpA-I levels in association with elevated levels of hepatic lipase provides new insights into the metabolism of HDL.
W.B. Saunders eBooksClinical trials in cardiovascular disease : a companion to Braunwald's heart disease
50 Citations1999Charles H. Hennekens, Eugene Braunwald
This study presents a meta-analysis of 26 Randomized Trials investigating the impact of cholesterol reduction, postmenopausal Hormone Replacement Therapy, and other Dietary Interventions on the risk of heart disease and stroke in women over the course of a 12-month period.
Developments in cardiovascular medicineA maximum confidence strategy for measuring progression and regression of coronary artery disease in clinical trials
18 Citations1993B. Greg Brown, Lynn A. Hillger +4 more
Two different arteriographic approaches were compared in a clinical trial, and the degree of concordance between disease change measured by these two approaches and clinical outcomes was assessed, leading to excellent agreement between these two fundamentally different methods of disease change assessment.
PubMedLipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.
17 Citations1998Brown Bg, Zhao Xq +8 more
Evidence supports the idea that substantial benefits may derive from treatments that increase high density lipoprotein (HDL) cholesterol, apolipoprotein (apo) A-I, HDL2 or the size of HDL particles with, or without, apo A-II, and the hypothesis that low HDL-C reflects an antioxidant deficiency state appears tenable.